|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/00 | (2006.01) |
| A61K 39/12 | (2006.01) |
| (11) | Number of the document | 3243526 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17177123.1 |
| Date of filing the European patent application | 2011-07-06 | |
| (97) | Date of publication of the European application | 2017-11-15 |
| (45) | Date of publication and mention of the grant of the patent | 2019-11-27 |
| (46) | Date of publication of the claims translation | 2020-02-10 |
| (30) | Number | Date | Country code |
| 361789 P | 2010-07-06 | US |
| (72) |
GEALL, Andrew, US
RAMSAUER, Katrin, US
OTTEN, Gillis, US
MANDL, Christian, US
|
| (73) |
GlaxoSmithKline Biologicals S.A.,
Rue de l`Institut, 89, 1330 Rixensart,
BE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | RNR pristatymas, skirtas keleto imuninio atsako paleidimui |
| DELIVERY OF RNA TO TRIGGER MULTIPLE IMMUNE PATHWAYS |
| Payment date | Validity (years) | Amount | |
| 2025-06-19 | 15 | 289.00 EUR |
| 2026-07-06 |